Prasugrel is Superior or Equivalent to Ticagrelor in ACS Patients undergoing PCI: A Systematic Review and Meta-Analysis
Meta-analysis of 9 trials indicates that prasugrel is equivalent or superior to ticagrelor in ACS patients undergoing PCI.
Efficacy and Safety of Sacubitril/Valsartan in HFrEF Patients with Low SBP: Insights from PARADIGM-HF
The present analysis evaluated the efficacy and safety of sacubitril/over enalapril in HF patients across different levels of SBP.
The present study is a critical appraisal of the existing evidence on the benefits and harms of sacubitril/valsartan in patients with HFrEF.
As per the study sacubitril/valsartan causes greater reduction in HbA1c vs. enalapril and cuts new insulin initiation in diabetes patients with...